PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Imipramine hydrochloride - Overactive bladder (adults)

PAD Profile : Imipramine hydrochloride - Overactive bladder (adults)

Keywords :
OAB, urge incontinence, urinary incontinence, urinary frequency, LUTS, overactive bladder, urinary urgency

Traffic Light Status

Status 1 of 1.

Status :
Non Formulary
Formulations :
  • Not Specified
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

Additional Documents

Type
Document
Review Date
Guidelines (Local)
01 September 2026

Committee Recommendations

Date
Committee Name
Narrative
05 February 2020
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

Imipramine is not recommended for treating overactive bladder in line with NICE NG123 - guidance can be found below

Associated BNF Codes

07. Obstetrics, Gynaecology and Urinary-Tract Disorders
07.04.02. Drugs for urinary frequency enuresis and incontinence
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More